Skip to content
Senegal
File

Senegal: medicines market regulation

This dossier follows Senegalese rules governing marketing authorisations for human medicines and the stages of their implementation.

Last updated : 1 key moments

Where things stand

Senegal's cabinet adopted a draft decree on marketing authorisations for human medicines on 28 October 2026, according to its statement.

Senegal's cabinet adopts draft decree on medicines authorisations

Senegal's cabinet adopted a draft decree on marketing authorisations for human medicines on 28 October 2026, according to its statement.

Vitamin D2 supplements, April 2019. Generic illustration, unrelated to any specific Senegalese authorisation. Mx. Granger, CC0.
Vitamin D2 supplements, April 2019. Generic illustration, unrelated to any specific Senegalese authorisation. Mx. Granger, CC0. — Mx. Granger / Wikimedia Commons — CC0 1.0 https://creativecommons.org/publicdomain/zero/1.0/ — compléments de vitamine D2, 20 avril 2019, recadrage existant, sans nouvelle modification.

The text addresses the conditions for granting, suspending and withdrawing authorisations. The statement records the cabinet's decision without detailing the new procedures.

It specifies neither an entry-into-force timetable nor transitional provisions. Those details remain to be checked in the published regulatory text.

Sources 2

Senegal: medicines market regulation · Moojaz